Abstract
Currently, few efficient therapies are available to battle pancreatic cancer. Mechanisms underlying this cancer are not well known and researchers are trying to identify new therapeutic targets. Here, we present a review of new treatments and their results in recent years.
Keywords: Angiogenesis, hedgehog- JAK-STAT – notch, immunotherapy, pancreatic cancer, stroma, target therapies.
Reviews on Recent Clinical Trials
Title:Pancreatic Cancer: Promises and Failures of Target Therapies
Volume: 11 Issue: 1
Author(s): Francesca Aroldi, Paola Bertocchi, Edoardo Rosso, Tiziana Prochilo and Alberto Zaniboni
Affiliation:
Keywords: Angiogenesis, hedgehog- JAK-STAT – notch, immunotherapy, pancreatic cancer, stroma, target therapies.
Abstract: Currently, few efficient therapies are available to battle pancreatic cancer. Mechanisms underlying this cancer are not well known and researchers are trying to identify new therapeutic targets. Here, we present a review of new treatments and their results in recent years.
Export Options
About this article
Cite this article as:
Aroldi Francesca, Bertocchi Paola, Rosso Edoardo, Prochilo Tiziana and Zaniboni Alberto, Pancreatic Cancer: Promises and Failures of Target Therapies, Reviews on Recent Clinical Trials 2016; 11 (1) . https://dx.doi.org/10.2174/1574887110666150930122720
DOI https://dx.doi.org/10.2174/1574887110666150930122720 |
Print ISSN 1574-8871 |
Publisher Name Bentham Science Publisher |
Online ISSN 1876-1038 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Regulation of Insulin Synthesis and Secretion and Pancreatic Beta-Cell Dysfunction in Diabetes
Current Diabetes Reviews Dynamic Simulations of Pathways Downstream of ERBB-Family, Including Mutations and Treatments: Concordance with Experimental Results
Current Cancer Drug Targets Exercise and Postprandial Glycemic Control in Type 2 Diabetes
Current Diabetes Reviews Tyrosine Kinase Blockers: New Hope for Successful Cancer Therapy
Anti-Cancer Agents in Medicinal Chemistry Pharmacological Exploitation of Indole-3-Carbinol to Develop Potent Antitumor Agents
Mini-Reviews in Medicinal Chemistry Vitamin D: A Regulator of Metabolism and Inflammation
Current Nutrition & Food Science Insulin Delivery Systems for Controlling Diabetes
Recent Patents on Endocrine, Metabolic & Immune Drug Discovery Mining the Dark Matter of the Cancer Proteome for Novel Biomarkers
Current Cancer Therapy Reviews Positron Emission Tomography and Computer Tomography (PET/CT) in Prostate, Bladder, and Testicular Cancers
Current Medicinal Chemistry Cancer: A Problem of Developmental Biology; Scientific Evidence for Reprogramming and Differentiation Therapy
Current Drug Targets Clinical Pharmacokinetics of Systemically Administered Antimycotics
Current Clinical Pharmacology Editorial (Diabetes, Obesity and Vascular Disease - An Update)
Current Pharmaceutical Design Ghrelin and Cardiovascular Diseases
Current Cardiology Reviews Death by Insulin: Management of Self-Harm and Suicide in Diabetes Management
Current Diabetes Reviews Interleukin-21 in Immune and Allergic Diseases
Inflammation & Allergy - Drug Targets (Discontinued) Gap Junctions as Targets for Cancer Chemoprevention and Chemotherapy
Current Drug Targets Anti-Inflammatory Approaches that Target the Chemokine Network
Recent Patents on Inflammation & Allergy Drug Discovery Therapeutic Effects of Melatonin On Liver And Kidney Damages In Intensive Exercise Model of Rats
Endocrine, Metabolic & Immune Disorders - Drug Targets The Effect of Lipoic Acid on Macro and Trace Metal Levels in Living Tissues Exposed to Oxidative Stress
Anti-Cancer Agents in Medicinal Chemistry From TGF-β to Cancer Therapy
Current Drug Targets